bpc 157 peptide multiple sclerosis Stable anti‐ulcer gastric pentadecapeptide also for sclerosis: Counteraction of cuprizone brain injuries and motor disability - Sikiric - 2013 - The FASEB Journal The Power of BPC-157 Peptide:
Description
It has major effects on the monocyte/macrophage systems, preventing the release of a substance that aids in fighting infection, Interleukin I
Cycle length Typical cycle: 12-16 weeks Minimum for results: 8 weeks Maximum recommended: 6 months continuous use AOD 9604 doesn't require cycling like some peptides
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL 33 mcg on a U-100 insulin syringe
References: Jastreboff AM, et al
Presentacin
